Resale players, meanwhile, will need to understand how this trend reshapes supply inflow, pricing elasticity, and category demand over time
According to new research, TMAO both causes and raises the HF ratio
It was originally approved for the treatment of type 2 diabetes by the FDA in May 2022 under the brand name Mounjaro, and then, in response to the significant weight loss results during clinical trials, the FDA approved tirzepatide in November 2023 for chronic weight management under the name Zepbound
However, effectiveness varies between individuals, and it is not a substitute for lifestyle changes
HepatoCORE supports liver function, fat metabolism, and cardiovascular health
Neurol Clin Pract 11:e504e507